Determination of a partial amino acid sequence for P D G F has shown that the two polypeptide chains are homologous with each other and that one of them is almost identical to part of p28sis, the transforming protein of simian sarcoma virus (SSV ) (Waterfield et al. 1983; Doolittle et al. 1983; Devare et a l. 1983; Johnsson et a l. 1984) . Sequence analysis of the human c-sis gene has established that it is identical to the gene for the B chain of P D G F (Josephs, Guo, Ratner & Wong-Staal, 1984; Chiu et a l. 1984; Johnsson et al. 1984) .
The close structural relationship between the B chain of PDGFand p28sls infers a corresponding functional homology; i.e. a PDGF-like growth factor may operate in SSV-induced transformation via interaction with the P D G F receptor and autocrine stimulation of growth. In support of this hypothesis, cell lysates and conditioned media of SSV-transformed cells have been found to contain growth factor activity that can be inhibited by P D G F antibodies (Deuel et al. 1983; Bowen-Pope, Vogel & Ross, 1984; Owen, Pantazis & Antoniades, 1984; Garrett et a l. 1984; Johnsson et a l. 19856) . Studies on the biosynthesis and maturation of p28sls have revealed that the product is rapidly dimerized and then proteolytically cleaved at both the N terminus and the C terminus (Robbins et al. 1983) . The structure of the active protein is thus probably very similar to a P D G F B -B homodimer.
If a secreted PDGF-like growth factor causes autocrine stimulation of growth via binding to cell surface P D G F receptors, one would expect that exogenously added P D G F antibodies would inhibit the growth of the producer cells. In order to test this prediction we have used human foreskin fibroblasts infected with SSV . Indeed, P D G F antibodies added to these cells inhibit their growth as well as normalize their transformed phenotype (Johnsson et al. 1985a) . Similarly P D G F antibodies have been found to inhibit the growth of other SSV-transformed cells (Huang, Huang & Deuel, 1984) . These data thus support the hypothesis that a PDGF-like growth factor is involved in SSV-induced cell transformation.
P R O D U C T IO N O F P D G F -L I K E G R O W T H F A C T O R S B Y N O R M A L A N D M A L IG N A N T C E L L S
Several recent observations indicate that PDGF-like growth factors may be implicated in autocrine stimulation of growth also in cell types other than SSVtransformed cells. Thus PDGF-like growth factors have been identified in the conditioned media of a variety of different cell types, normal as well as malignant (Table 1) . We have partially purified and characterized the factors produced by human osteosarcoma and glioma cell lines. Their structural and functional character istics are similar and possibly identical to P D G F (Heldin, Westermark & Wasteson, 1980; Nister, Heldin, Wasteson & Westermark, 1984; Betsholtz et a l. 1983) . Thus it is possible that the normal gene(s) for P D G F are aberrantly expressed in these cell lines. An involvement of PDGF-like growth factors in certain forms of neoplasia may not be uncommon since m-related 4-2X103 base-pair transcripts have been found in a high proportion of sarcoma and glioma cell lines, i.e. cell types that carry P D G F receptors (Eva et a l. 1982) .
In order to investigate whether the endogenous production of a PDGF-like growth factor causes autocrine stimulation of growth, we studied the human osteosarcoma cell line U -2 OS. These cells do not show any specific binding of P D G F (Heldin, Westermark & Wasteson, 1981) . Though this is probably due to receptor blocking and down regulation, and may as such be a sign of functional activity of the endogenously produced growth factor, it poses a practical problem when one wants to prove that the same cells that produce the growth factor also respond to it. If there is an inverse relationship between growth factor production and receptor number, one would expect to find receptors on cells that produce less growth factor. Indeed a low-producer clone of the osteosarcoma cells had a certain number of specific binding sites for [12SI]P D G F (Betsholtz, Westermark, Ek & Heldin, 1984) . These receptors were functional; P D G F stimulated tyrosine phosphorylation of a 185X \Qi M r com ponent, which is probably the P D G F receptor itself (see below), in membranes as well as in intact cells (Betsholtz et al. 1984) . Immunoprécipitation of metabolically labelled osteosarcoma cells using an antiserum against phosphotyrosine revealed that (Josephs et al. 1984) , several additional osteosarcoma and glioma cell lines (Eva et al. 1982 ) and a smooth muscle tumour cell line (Norris et al. 1984) , have been shown to express c-sis and are therefore likely to produce PDGF-like growth factors. a ll S x l O 3 M t component was constitutively phosphorylated in these cells. Since a component of similar M t is also phosphorylated in human fibroblasts, but only after stimulation with P D G F (Ek & Heldin, 1984) , this may reflect the fact that the postreceptor pathway is permanently activated in these cells.
T able 1. Production by various cell types o f PD G F-like growth factors
Evidence for autocrine receptor activation in this clone of osteosarcoma cells was thus obtained. However, contrary to our findings with SSV-transformed cells, antibodies against P D G F had no effect on the growth rate of these cells (Betsholtz et a l. 1984, and unpublished) . Similarly P D G F antibodies have no effect on the growth of human glioma cell lines producing PDGF-like growth factors (Nister et a l ., unpublished). Therefore, it is possible that the endogenous production of PD G F-like growth factors has no significance for the growth of the cells. Alterna tively, the endogenously produced growth factor may activate the P D G F receptor at a site where it is inaccessible to exogenously added antibodies, e.g. the interaction may take place inside the cell and involve newly synthesized receptors before they are inserted in the membrane.
One of the PDGF-producing glioma cell lines was cloned and individual cell clones analysed with regard to P D G F production and P D G F binding. Examination of about 80 different clones revealed a remarkable variability between different clones in both these parameters (Nister et a l. 1985) . Clones producing much of the PD G F-like growth factor were, as expected, found to have a low number of P D G F receptors. However, several low producers also showed a low binding of [125I]P D G F , suggesting that a clonal variation in the expression of the genes for both the growth factor and the P D G F receptor. A correlation was found between the amount of P D G F produced and the growth rate of the cells under serum-free conditions, supporting the assumption that the endogenous growth factor pro duction is of significance for autocrine growth stimulation. Furthermore, a corre lation was noticed between P D G F production and passage level, indicating that high-producer cells may have a growth advantage over low-producer cells.
Taken together, the available data support the assumption that PDGF-like growth factors may participate in autocrine stimulation of growth. This may then occur via two different mechanisms. One is represented by SSV-transformed human fibro blasts, where the growth factor is secreted from the cell and where exogenously added P D G F antibodies inhibit the stimulation (Fig. 1a ) . The other one is represented by certain human osteosarcoma and glioma cell lines, where a significant portion of the receptor activation occurs in a compartment inaccessible to P D G F antibodies (Fig. 1b ) .
T H E P D G F R E C E P T O R P D G F exerts its mitogenic action via binding to specific cell surface receptors on responsive cells (Heldin et al. 1981) . The receptor is a transmembrane glycoprotein of M r 185X103 (Glenn, Bowen-Pope & Ross, 1982; Heldin, Ek & Ronnstrand, 1983) . It is composed of two functional parts, an extracellular ligand binding domain, and an intracellular effector domain with an associated PDGF-stimulatable T h e endogenously produced growth factor is exported from the cell and interacts with growth factor receptors at the cell surface. B. T h e endogenous growth factor interacts with and activates newly synthesized growth factor receptors inside the cell, before they have reached the cell surface. Reproduced with permission from B etsh o ltzei a l. (1984) . E R , endoplasmic reticulum ; G , Golgi apparatus; S V , secretory vesicle. tyrosine kinase activity (Ek, Westermark, Wasteson & Heldin, 1982; Nishimura, Huang & Deuel, 1982; Pike, Bowen-Pope, Ross & Krebs, 1983) . The kinase activity is likely to be an integral part of the receptor molecule, since it has affinity for P D G FSepharose (Heldin et a l. 1983 ) and since the kinase activity remains associated with highly purified receptor preparations (Rônnstrand et a l., unpublished) . The functional organization of the P D G F receptor is thus very similar to that of other tyrosine kinase associated growth factor receptors, e.g. the receptors for epidermal growth factor (E G F ) (Cohen, Ushiro, Stoscheck & Chinkers, 1982) , insulin (Kasuga et al. 1983 ) and insulin-like growth factor I (Jacobs et a l. 1983). That tyrosine phosphorylation is involved in control of cell proliferation is further supported by the findings that several oncogene products are tyrosine kinases (Bishop, 1983) .
Incubation of membranes from human fibroblasts with P D G F and radioactively labelled A TP led to the phosphorylation of components of 185X103 and 130X103M r (Ek et al. 1982; Ek & Heldin, 1982) . The 185X103 M r component represents the P D G F receptor proper, which undergoes autophosphorylation (Heldin et a l. 1983) . The 130X103 M r component is a fragment of the receptor, formed after cleavage by an endogenous Ca2+-dependent SH-protease (Ek & Heldin, unpublished) . The degraded form of the receptor retains kinase activity. It is not known whether this proteolysis has any significance in the mechanism of action of P D G F.
Autophosphorylation of the P D G F receptor on tyrosine residues also occurs in intact cells (Ek & Heldin, 1984) . Furthermore, the receptor of intact fibroblasts was also found to contain phosphate bound to serine residues. This suggests that the various functional properties of the receptor, i.e. ligand binding, kinase activity and receptor turnover, may be regulated by phosphorylations involving two different types of kinases: autophosphorylation on tyrosine residues and phosphorylation on serine residues by as yet unidentified kinases.
M echanism o f action o f PD G F
The mechanism whereby the mitogenic signal is transmitted from the activated P D G F receptor further into the cell is largely unknown. In view of the functional homology between several growth factor receptors and certain oncogene products, it is likely that the receptor-associated tyrosine kinase is involved. Several methods have been used to identify substrates for the P D G F receptor kinase. Cooper et al. (1982) analysed lysates from metabolically labelled, PDGF-stimulated cells by two dimensional electrophoresis; gels were then treated with alkali in order to hydrolyse phosphoserine. This method revealed certain components in the M r region 45X 103 to 43X 103 in both 3T3 cells and human fibroblasts. Nakamura, Martinez & Weber (1983) found the major increase in tyrosine phosphorylation in PDGF-stimulated chick cells in the same Mr region. Another approach was taken by Ek & Heldin (1984) and Frackelton, Tremble & Williams (1984) , who used antisera that specifi cally recognize phosphotyrosine. This method identified the P D G F receptor as the major tyrosine-phosphorylated component in PDGF-stimulated cells. In addition, several other components were found, including a 1 1 5X l03M r component. The function of these components, or their involvement in PDGF-stimulated mitogenesis, is not known.
Other rapid effects of PD G F on cells include activation of protein kinase C (Rozengurt, Rodriguez-Pena & Smith, 1983) , a serine/threonine kinase, which is the target for certain tumour promoters (Castagna et a l. 1982) , as well as mobilization of Ca2+ from intracellular pools (Moolenar, Tertoolen & de Laat, 1984) . Both these effects, which are likely to be important in the mitogenic pathway, can be explained by the stimulatory effect of P D G F on phosphatidylinositol metabolism (Habenicht et a l. 1981; Berridge, Heslop, Irvine & Brown, 1984) . This results in breakdown of phosphatidylinositol bisphosphate to diacylglycerol and inositol trisphosphate, which activates protein kinase C (Nishizuka, 1984) and mobilizes Ca2+ (Berridge & Irvine, 1984) , respectively. P D G F also rapidly stimulates the amiloride-sensitive NA+/H+ exchanger (Burns & Rozengurt, 1983; Cassel et a l. 1983) , leading to an alkalinization of the cytoplasm.
It is known that gene expression is a necessary event in PDGF-stimulated mitogenesis since inhibitors of mRNA synthesis block cell proliferation (Smith & Stiles, 1981) . Recent studies have indicated that P D G F induces the genes of several proteins (Pledger, Hart, Locatell & Scher, 1981; Cochran, Reffel & Stiles, 1983; Linzer & Nathans, 1983) , including c-myc (Kelly, Cochran, Stiles & Leder, 1983) and c-fos (Greenberg & Ziff, 1984) . It is possible that the products of c-myc and c-fos, which are localized in the nucleus, function as regulators of the expression of the genetic program that controls cell proliferation.
R E L A T I O N S H I P B E T W E E N T H E M E C H A N IS M O F A C T IO N O F G R O W T H F A C T O R S A N D O N C O G E N E P R O D U C T S
In conclusion, studies on P D G F and cellular components linked to its action have revealed several connections with retroviral oncogenes. Together with additional information from studies on other growth factors, this suggests that proto-oncogenes encode proteins that operate in the regulation of normal mitogenesis or differen tiation; these genes may obtain transforming potential by aberrant expression, mutation or recombination, leading to the synthesis of proteins that perturb the mitogenic pathway at a regulatory point (see Heldin & Westermark, 1984) . Fig. 2 illustrates schematically the mitogenic pathway of growth factors and how one can envisage that various retroviral oncogenes interfere with this pathway at different levels. The basis for the assignment of the oncogenes to various levels of growth factor action is the current knowledge of their amino acid sequence, enzymic activity and subcellular localization (for references, see reviews by Bishop, 1983; Land, Parada & Weinberg, 1983; Heldin & Westermark, 1984; Hunter, 1984) .
(1) Oncogenes may code for a growth factor that acts by autocrine stimulation of growth. The sis product, which is a P D G F agonist, is an example in this category.
(2) Oncogenes may code for proteins that mimic the action of activated growth factor receptors. The erbB product, which corresponds to a truncated E G F receptor ( Downward et al. 1984) , is an example in this group. Other oncogene products with tyrosine kinase activity may also belong to this category. T h e fm s product has not yet been shown to be a tyrosine kinase, but since it has an extensive amino acid homology with the tyrosine kinases and is probably a membrane protein (Hampe, G obet, Sherr & Galibert, 1984) , it has been placed in this group.
(3) T h e oncogene products of mos (Kloetzer, Maxwell & Arlinghaus, 1983) and raf/m il (Moelling et al. 1984) have been shown to have serine/threonine kinase activity. These proteins may thus be involved in growth stimulation in a manner similar to protein kinase C, which is a serine/threonine kinase that is activated by P D G F and other growth factors.
(4) Of the group of nuclear oncogene products, at least two, the products of myc and fo s , have normal counterparts that are induced by growth factors.
(5) T h e ras family of oncogene products constitute a separate group. T h eir products are localized at the cell surface, have G T Pase activity and have a structural homology with signal transducing G proteins linked to the adenylate cyclase or other effector systems (Hurley et al. 1984) . T h eir activity is required late in G j, immediately before the S phase (Mulcahy, Smith & Stacey, 1985) .
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